Platelets in Thrombosis and Atherosclerosis A Double-Edged Sword

被引:7
|
作者
Bravo, Gabriela Martinez [1 ]
Annarapu, Gowtham [5 ]
Carmona, Emely [6 ]
Nawarskas, James [2 ]
Clark, Ross [3 ,4 ]
Novelli, Enrico [5 ,6 ]
Alvidrez, Roberto I. Mota [1 ,2 ,4 ]
机构
[1] Univ New Mexico, Biomed Engn Dept, Albuquerque, NM USA
[2] Univ New Mexico, Pharmaceut Sci Pharm Practice, Albuquerque, NM USA
[3] Univ New Mexico, Coll Pharm Cell Biol & Physiol, Albuquerque, NM USA
[4] Univ New Mexico, Clin & Translat Sci Ctr, Albuquerque, NM USA
[5] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA
[6] Univ Pittsburgh, Med Ctr, Sch Med, Pittsburgh, PA USA
来源
AMERICAN JOURNAL OF PATHOLOGY | 2024年 / 194卷 / 09期
关键词
ACUTE CORONARY SYNDROMES; VON-WILLEBRAND-FACTOR; TISSUE FACTOR; P-SELECTIN; INFLAMMATION; MECHANISMS; RECEPTOR; INHIBITION; HEMOSTASIS; DISEASE;
D O I
10.1016/j.ajpath.2024.05.010
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This review focuses on the dual role of platelets in atherosclerosis and thrombosis, exploring their involvement in inflammation, angiogenesis, and plaque formation, as well as their hemostatic and pro- thrombotic functions. Beyond their thrombotic functions, platelets engage in complex interactions with diverse cell types, influencing disease resolution and progression. The contribution of platelet degranulation helps in the formation of atheromatous plaque, whereas the reciprocal interaction with monocytes adds complexity. Alterations in platelet membrane receptors and signaling cascades contribute to advanced atherosclerosis, culminating in atherothrombotic events. Understanding these multifaceted roles of platelets will lead to the development of targeted antiplatelet strategies for effective cardiovascular disease prevention and treatment. Understanding platelet functions in atherosclerosis and atherothrombosis at different stages of disease will be critical for designing targeted treatments and medications to prevent or cure the disease Through this understanding, platelets can be targeted at specific times in the atherosclerosis process, possibly preventing the development of atherothrombosis.
引用
收藏
页码:1608 / 1621
页数:14
相关论文
共 50 条
  • [41] AMLODIPINE DOUBLE-EDGED SWORD
    Rabah, Fatma
    Elnour, Ibtisam B.
    El-Naggari, Mohamed
    Al-Nabhani, Dana
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1657 - 1657
  • [42] Akt: a double-edged sword
    Meera Swami
    Nature Reviews Cancer, 2009, 9 : 76 - 77
  • [43] CpG: The double-edged sword
    Paillard, F
    HUMAN GENE THERAPY, 1999, 10 (13) : 2089 - 2090
  • [44] Feedback: a double-edged sword
    不详
    IN PRACTICE, 2014, 36 (09) : 480 - 480
  • [45] Morphine - A double-edged sword
    Shavit, Y
    Beilin, B
    PAIN FORUM, 1996, 5 (04): : 237 - 239
  • [46] Another double-edged sword
    不详
    IEEE SPECTRUM, 2003, 40 (11) : 11 - 11
  • [47] Prioritization: A Double-Edged Sword?
    Burns, Catherine M.
    Naikar, Neelam
    JOURNAL OF COGNITIVE ENGINEERING AND DECISION MAKING, 2016, 10 (01) : 105 - 108
  • [48] A double-edged sword for NSCLC?
    Alessia Errico
    Nature Reviews Clinical Oncology, 2014, 11 (2) : 66 - 66
  • [49] Natalizumab: A Double-Edged Sword?
    DeAngelis, Lisa M.
    ANNALS OF NEUROLOGY, 2009, 66 (03) : 262 - 263
  • [50] The double-edged sword of evolution
    Kruzel-Davila, Etty
    Skorecki, Karl
    ELIFE, 2017, 6